Um die volle Funktionalität der Webseite nutzen zu können, müssen Sie JavaScript in ihrem Browser aktivieren.

DAX23.317,14-1,15 %

Gold3.379,15-0,28 %

Öl (Brent)76,41+4,82 %

Dow Jones42.196,80-0,67 %

US Tech 10021.718,77-0,92 %

EUR/USD1,14981+0,12 %

Top 15 der gesamten Suchanfragen der letzten 7 Tage

Login

Zenas BioPharma Aktie

Aktie

ISIN: US98937L1052 WKN: A40MUX SYM: ZBIO Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

9,6800

USD

-2,91 %

-0,2900 USD

Letzter Kurs 02:00:00 Nasdaq

Zenas BioPharma Aktie kaufen

Geldkurs

17.06.25

9,7000

USD

900 STK

Briefkurs

17.06.25

9,7900

USD

200 STK

BEI SMARTBROKER+ HANDELN

Handeln über unsere
Partner-Broker

Brokerize

Neueste Nachrichten

ZBIO Investors Have Opportunity to Lead Zenas BioPharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm 16.06.25 · Business Wire (engl.) · Zenas BioPharma
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma 16.06.25 · Business Wire (engl.) · Zenas BioPharma
ZBIO DEADLINE NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 16 Deadline in Securities Class Action First Filed by the Firm - ZBIO 15.06.25 · newsfile · Zenas BioPharma
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma 14.06.25 · newsfile · Zenas BioPharma
ZBIO DEADLINE MONDAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Zenas BioPharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 16 Deadline in Securities Class Action First Filed by the Firm - ZBIO 14.06.25 · newsfile · Zenas BioPharma
ZBIO Investors Have the Opportunity to Lead the Zenas BioPharma Securities Fraud Lawsuit with Faruqi & Faruqi, LLP 13.06.25 · newsfile · Zenas BioPharma
ZBIO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 16 Deadline in Securities Class Action First Filed by the Firm - ZBIO 12.06.25 · newsfile · Zenas BioPharma
Faruqi & Faruqi Reminds Zenas BioPharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 16, 2025 - ZBIO 11.06.25 · newsfile · Zenas BioPharma
INVESTOR DEADLINE NEXT WEEK: Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - ZBIO 10.06.25 · newsfile · Zenas BioPharma
ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit 10.06.25 · newsfile · Zenas BioPharma
ZBIO DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 16 Deadline in Securities Class Action First Filed by the Firm - ZBIO 09.06.25 · newsfile · Zenas BioPharma
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma 09.06.25 · newsfile · Zenas BioPharma

1
2
3
4
5
…
8

Meistgelesen

7 Tage
30 Tage
12 Monate

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma 116 Leser
Faruqi & Faruqi Reminds Zenas BioPharma Investors of the Pending Class Action Lawsuit with a Lead ... 112 Leser
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ... 108 Leser
ZBIO Investors Have Opportunity to Lead Zenas BioPharma, Inc. Securities Fraud Lawsuit with the ... 108 Leser
ZBIO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors with ... 104 Leser
ZBIO Investors Have the Opportunity to Lead the Zenas BioPharma Securities Fraud Lawsuit with ... 104 Leser
ZBIO DEADLINE NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. ... 104 Leser
ZBIO DEADLINE MONDAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Zenas BioPharma, Inc. Investors ... 100 Leser

ZBIO DEADLINE NOTICE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. ... 132 Leser
ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel ... 120 Leser
ZBIO Investors Have the Opportunity to Lead the Zenas BioPharma Securities Fraud Lawsuit with ... 120 Leser
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before ... 120 Leser
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ... 120 Leser
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma 116 Leser
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma 116 Leser
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ... 116 Leser
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ... 116 Leser
ROSEN, SKILLED INVESTOR COUNESL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel ... 116 Leser

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel ... 164 Leser
Zenas BioPharma Appoints Lisa von Moltke, M.D., as Head of Research and Development and Chief ... 140 Leser
Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in ... 136 Leser
ZBIO DEADLINE NOTICE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. ... 132 Leser
Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates 132 Leser
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ... 120 Leser
ZBIO Investors Have the Opportunity to Lead the Zenas BioPharma Securities Fraud Lawsuit with ... 120 Leser
ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel ... 120 Leser
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before ... 120 Leser
ZBIO INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Zenas BioPharma, Inc. Investors with Substantial ... 120 Leser